mesenchymal stem cell-derived exosomes (Pandorum Technologies)

N/A

Report date: 2025/03/20 15:28:48

Base Information

Drug Namemesenchymal stem cell-derived exosomes (Pandorum Technologies)

Drug Alias NameKuragenx

ClassificationBiologics > Exosomes > Stem cell-derived exosomesCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsKeratitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIndia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPandorum Technologies Pvt Ltd

China Registration ClassN/A

Develop Information

Active CompaniesPandorum Technologies Pvt Ltd

Inactive CompaniesN/A

Active IndicationsKeratitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A